ANI PHARMACEUTICALS, INC Treasury Stock, Common, Shares
ANI PHARMACEUTICALS, INC (ANIP) had Treasury Stock, Common, Shares of 891.91 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure
us-gaap:TreasuryStockCommonShares · last filed 2026-08-07
- 2026-06-30: Treasury Stock, Common, Shares 891.91K shares.
- 2026-03-31: Treasury Stock, Common, Shares 881.49K shares.
- 2025-12-31: Treasury Stock, Common, Shares 621.30K shares.
- 2025-09-30: Treasury Stock, Common, Shares 613.97K shares.
| Period end | Treasury Stock, Common, Shares |
|---|---|
| 2026-06-30 | 891.91K shares 10-Q · filed 2026-08-07 |
| 2026-03-31 | 881.49K shares 10-Q · filed 2026-05-08 |
| 2025-12-31 | 621.30K shares 10-Q · filed 2026-08-07 |
| 2025-09-30 | 613.97K shares 10-Q · filed 2025-11-07 |
| 2025-06-30 | 601.99K shares 10-Q · filed 2025-08-08 |
| 2025-03-31 | 592.96K shares 10-Q · filed 2025-05-09 |
| 2024-12-31 | 429.56K shares 10-K · filed 2026-02-27 |
| 2024-09-30 | 423.94K shares 10-Q · filed 2024-11-08 |
| 2024-06-30 | 412.59K shares 10-Q · filed 2024-08-06 |
| 2024-03-31 | 392.96K shares 10-Q · filed 2024-05-10 |
| 2023-12-31 | 263.94K shares 10-K · filed 2025-02-28 |
| 2023-09-30 | 259.55K shares 10-Q · filed 2023-11-08 |
| 2023-06-30 | 248.36K shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 233.52K shares 10-Q · filed 2023-05-08 |
| 2022-12-31 | 149.03K shares 10-K · filed 2024-02-29 |
| 2022-09-30 | 145.85K shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 139.11K shares 10-Q · filed 2022-08-08 |
| 2022-03-31 | 122.71K shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 82.66K shares 10-K · filed 2023-03-09 |
| 2021-09-30 | 82.66K shares 10-Q · filed 2021-11-01 |
| 2021-06-30 | 80.08K shares 10-Q · filed 2021-08-06 |
| 2021-03-31 | 86.03K shares 10-Q · filed 2021-05-07 |
| 2020-12-31 | 75.52K shares 10-K · filed 2022-03-15 |
| 2020-09-30 | 75.52K shares 10-Q · filed 2020-11-05 |
| 2020-06-30 | 57.89K shares 10-Q · filed 2020-08-06 |
| 2020-03-31 | 27.87K shares 10-Q · filed 2020-05-07 |
| 2019-12-31 | 15.31K shares 10-K · filed 2021-03-11 |
| 2019-09-30 | 12.31K shares 10-Q · filed 2019-11-06 |
| 2019-06-30 | 12.31K shares 10-Q · filed 2019-08-07 |
| 2019-03-31 | 2.00K shares 10-Q · filed 2019-05-09 |
| 2018-12-31 | 11.18K shares 10-K · filed 2020-02-27 |
| 2018-09-30 | 11.18K shares 10-Q · filed 2018-11-06 |
| 2018-06-30 | 11.18K shares 10-Q · filed 2018-08-07 |
| 2018-03-31 | 4.29K shares 10-Q · filed 2018-05-08 |
| 2017-12-31 | 5.20K shares 10-K · filed 2019-02-27 |
| 2017-09-30 | 5.20K shares 10-Q · filed 2017-11-02 |
| 2017-06-30 | 5.20K shares 10-Q · filed 2018-08-07 |
| 2016-12-31 | 0.00 shares 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |